Lynx1 Capital Management LP PTGX Holdings History
Lynx1 Capital Management LP's Protagonist Therapeutics Inc Holding Summary
As of 2025-03-31, Lynx1 Capital Management LP held 733,014.00 shares of Protagonist Therapeutics Inc(PTGX), totaling $35.45 Mil. This investment constitutes 12.69% of their stock portfolio, and Lynx1 Capital Management LP now holds 1.18% of the outstanding Protagonist Therapeutics Inc(PTGX) stock.
The initial trade took place in 2025Q1. And since then Lynx1 Capital Management LP has made 1 purchases of PTGX, at an average price of $41.90, for a total of 733,014.00 shares. Based on historical transaction data and PTGX's current price of $53.74, Lynx1 Capital Management LP's estimated gain on his PTGX holdings is $8.68 Mil, reflecting a 28.26% gain to date.
Lynx1 Capital Management LP PTGX ($53.74) Holding Chart
Lynx1 Capital Management LP PTGX ($53.74) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
